XML 57 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations - Held for Sale, Results of Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Loss from discontinued operations        
Net loss from discontinued operations, net of tax $ (14,185) $ (5,355) $ (58,905) $ (18,484)
DoseMe and SinfonaRx businesses | Discontinued Operations, Held-for-sale        
Loss from discontinued operations        
Revenue 6,407 8,143 23,094 26,961
Cost of revenue, exclusive of depreciation and amortization 7,055 6,521 20,479 19,755
Operating expenses 3,879 5,659 13,639 18,827
Impairment charges 5,845   21,648  
Loss from discontinued operations before income taxes (10,372) (4,037) (32,672) (11,621)
Income tax (benefit) expense (83) 40 (363) 116
Net loss from discontinued operations, net of tax $ (10,289) $ (4,077) $ (32,309) $ (11,737)